MENU
ITOS
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
iTeos Therapeutics (ITOS) Ownership - Who owns iTeos Therapeutics?
ITeos Therapeutics Inc is a biopharmaceutical company... Show more
Profile
Industry
N/A
Address
321 Arsenal Street
Phone
+1 339 217-0162
Employees
157
Web
https://www.iteostherapeutics.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
447.8M
P/E Ratio
N/A
Total Cash
515.43M
Projected Growth
N/A
Total Debt
5.13M
Revenue
N/A
Risk (Beta)
1.51
Dividend Yield
N/A
Total Cash/Share
11.66
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
ITOS
Capitalization
448M
P/E Ratio
N/A
Risk (Beta)
1.51
Dividend Yield
N/A
Total Cash
515M
Total Cash/Share
11.66
Total Debt
5.13M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
494M
P/B Ratio
0.91
Cash Flow
N/A
Earnings
-4.73
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
44K
Current Ratio
7.53
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-200.45M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-29.44
Shares Held By Institutions
428M
Shares Outstanding - Current
44.2M
Total Liabilities
129M
Total Volume MTD
N/A
Value
N/A
Gain YTD
31.901
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. ITOS showed earnings on August 28, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information
General Information
a company, which engages in the development of biopharmaceuticals therapeutic products and services
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
321 Arsenal Street
Phone
+1 339 217-0162
Employees
157
Web
https://www.iteostherapeutics.com